Urological conditions and COVID-19 (search done on 8 April 2020)

Added July 22, 2020

Citation: Chan VW, Chiu PK, Yee CH, et al. A systematic review on COVID-19: urological manifestations, viral RNA detection and special considerations in urological conditions. World Journal of Urology. 2020 May 27:1-12.

What is this? Some patients with COVID-19 will have existing chronic health problems, such as urological conditions, and information on the manifestations of comorbidities in patients with COVID-19 might provide useful information for patients and those providing their health care.

In this rapid review, the authors searched for studies on the urological clinical manifestations, viral RNA detection and other considerations for COVID-19 patients with urological conditions. They restricted their searches to articles published in English and did the search on 8 April 2020. They included 21 studies (3714 COVID-19 patients) of urinary or gastrointestinal symptoms; 11 studies (195 patients) and 12 studies (325 patients) in which patients had their urine or stools (respectively) tested for SARS-CoV-2 viral RNA; 6 studies reporting a total of 19 cases of COVID-19 in renal transplant recipients and 12 studies (3266 patients) in a meta-analysis of acute kidney injury among COVID-19 patients.

What was found: At the time of this review, the included studies showed that urinary symptoms were unlikely to be a clinical manifestation of COVID-19.

At the time of this review, the included studies showed that viral RNA positivity was detected in both urine and stool samples, suggesting the need for precautions during transurethral or transrectal procedures.

At the time of this review, the included studies suggested that renal transplant patients might have a higher COVID-19 mortality rate than the general population.

At the time of this review, the included studies showed that acute kidney injury leading to mortality was common amongst COVID-19 patients.


Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence on the coronavirus (COVID-19) but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about the coronavirus (COVID-19) on the basis of this summary alone.